Kopin IJ, Fischer JE, Musacchio JM et al: Evidence for a false neuro-chemical transmitter as a mechanism for the hypotensive effect of monoamine oxidase inhibitors. Proc Natl Acad Sci USA52:716-721.1964
2.
Dawson AM, Sherlock S.: Effect of an amine-oxidase inhibitor on arterial ammonium levels in liver disease. Lancet1:1332-1333, 1957
3.
Freund HR, Dienstag J., Lehrich F., et al: Infusion of branched-chain amino acid solution in patients with hepatic encephalopathy. Ann Surg196:209-220, 1982
4.
Marchesini G. , Zoli M., Dondi C., et al: Anticatabolic effects of branched-chain amino acid-enriched solutions in patients with liver cirrhosis . Hepatology2:420-425, 1982
5.
Fischer JE, Yoshimura N., James JH, et al: Plasma amino acids in patients with hepatic encephalopathy: Effects of amino acid infusions. Am J Surg127:40-49, 1974
6.
James JH, Fischer JE: Release of octopamine and α-methyl-octopamine by L-dopa. Biochem Pharmacol24:1099-1101, 1975
7.
James JH, Hodgman JM, Funovics JM, et al: Alterations in brain octopamine and brain tyrosine following portacaval anastomosis in rats. J Neurochem27:223-227, 1976
8.
Rosen HM, Yoshimura N., Hodgman JM, et al: Plasma amino acid patterns in hepatic encephalopathy of differing etiology. Gastroenterology72:483-487, 1977
9.
James JH, Escourrou J., Fischer JE: Blood-brain neutral amino acid transport activity is increased after portacaval anastomosis. Science200:1395-1397, 1978
10.
James JH, Jeppsson B., Ziparo V., et al: Hyperammonemia, plasma amino acid imbalance, and blood-brain amino acid transport: A unified theory of portal-systemic encephalopathy. Lancet2:772-775, 1979
11.
Smith AR, Rossi-Fanelli F., Ziparo V., et al: Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg187:343-350, 1978
12.
Baldessarini RJ, Fischer JE: Serotonin metabolism in rat brain after surgical diversion of the portal venous circulation. Nature (New Biol)254:25-27, 1973
13.
Fischer JE, Baldessarini RJ: False neurotransmitters and hepatic failure. Lancet2:75-80, 1971
14.
Fischer JE, Tiao GM: Nutritional support in hepatic failure. In Nutrition and Metabolism in the Surgical Patient, 2nd ed. Fischer JE (ed). Little, Brown and Company , Boston, 1996 , p 637-651
15.
Fischer JE, Rosen EM, Ebeid AM, et al: The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery80:77-91, 1976
16.
Naylor CD, O'Rourke K., Detsky AS, et al: Parenteral nutrition with branched-chain amino acids in hepatic encephalopathy: A meta-analysis. Gastroenterology97:1033-1042, 1989
17.
Fan ST, Lo CM, Lai ECS, et al: Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma. N Engl J Med331:1547-1552, 1994
18.
Freund H., Ryan JA, Fischer JE: Amino acid derangements in patients with sepsis: Treatment with branched chain amino acid rich infusions. Ann Surg188:423-430, 1978
19.
Gimmon Z., Freund HR, Fischer JE: The optimal branched chain to total amino acid ratio in the injury-adapted amino acid formulation. JPEN9:133-138, 1985
20.
Bower RH, Muggia-Sullam M., Vallgren S., et al: Branched chain amino acid-enriched solutions in the septic patient: A randomized, prospective trial. Ann Surg203:13-20, 1986
21.
Cerra FB, Upson D., Angelico R., et al: Branched chains support postoperative protein synthesis. Surgery92:192-199, 1982
22.
Daly JM, Mihranian MH, Kehoe JE, et al: Effects of postoperative infusion of branched chain amino acids on nitrogen balance and forearm muscle substrate flux. Surgery94:151-158, 1983
23.
Hall-Angerås M., Angerås U., Zamir O., et al: Effect of the glucocorticoid receptor antagonist RU38486 on muscle protein breakdown in sepsis. Surgery109:468-473, 1991
24.
Hall-Angerås M., Angerås U., Zamir O., et al: Interaction between corticosterone and tumor necrosis factor stimulated protein breakdown in rat skeletal muscle, similar to sepsis. Surgery108:460-466, 1990
25.
Hasselgren PO, James JH, Benson DW, et al: Total and myofibrillar protein breakdown in different types of rat skeletal muscle: Effects of sepsis and regulation by insulin. Metabolism38:634-640, 1989
26.
Hasselgren PO, James JH, Warner BW, et al: Reduced muscle amino acid uptake in sepsis and the effects in vitro of septic plasma and interleukin-1. Surgery100:222-228, 1986
27.
Tiao G., Fagan JM, Samuels N., et al: Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest94:2255-2264, 1994
28.
Ciechanover A., Hod Y., Hershko A.: A heat-stable polypeptide component of an ATP-dependent proteolytic system from reticulocytes. Biochem Biophys Res Commun81:1100-1105, 1978
29.
Hershko A., Ciechanover A.: The ubiquitin system for protein degradation. Annu Rev Biochem61:761-807, 1992
30.
Tiao G., Fagan J., Roegner V., et al: Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J Clin Invest97:339-348, 1996
31.
Weissman JS , Sigler PB, Horwich AL: From the cradle to the grave: ring complexes in the life of a protein. Science268:523-524, 1995
32.
Ma CP, Slaughter CA, DeMartino GN: Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J Biol Chem267:10515-10523, 1992
33.
Tiao G., Fagan J., Lieberman, M., et al: Sepsis increases proteasome-dependent proteolysis and mRNA levels for the proteasome subunit RC3 in skeletal muscles. Surg Forum46:10-12, 1995
34.
Hasselgren PO : Protein Metabolism in Sepsis. R. G. Landes Company, Austin, TX, 1993
